News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arena Pharmaceuticals, Inc. (ARNA) Picks Japan's Eisai Inc. (ESALF.PK) To Market Obesity Drug Lorcaserin In Deal Worth $1.3 Billion Potentially


7/1/2010 6:24:32 AM

AP -- Arena Pharmaceuticals Inc. said Thursday it has an agreement with Japan's Eisai Inc. in a deal worth potentially more than $1.3 billion to fund commercialization of an obesity drug that could become Arena's first product.

Read at Wall Street Journal
Read at BusinessWeek
Read at AP
Read at News Release
Read at Market Watch


comments powered by Disqus
   
Obesity

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES